logo
Plus   Neg
Share
Email

Accor Reports Purchase Of Three Hotel Asset Portfolios In Europe For EUR284 Mln

French hotel group Accor (ACRFY.PK,ACRFF.PK) Tuesday reported the purchase of three hotel asset portfolios in Europe, representing 29 hotels with 3,677 rooms, for a total of 284 million euros.

The transactions include a portfolio acquired from AXA Investment Managers - Real Assets for 56 million euros, a portfolio purchased from Invesco for 152 million euros, which comprises six hotels, and a portfolio purchased from Deutsche AWM for 76 million euros.

The two first deals are scheduled to be finalized during first-half 2016, and the transaction with Deutsche AWM was finalized on November 27.

John Ozinga, Chief Operating Officer of HotelInvest, Europe's leading hotel investor, said, "The transformation of HotelInvest is continuing at a fast pace, with close to €1.0 billion worth of real-estate transactions secured in 2015. We are on track with our roadmap and with the completion of our three-year plan to significantly increase Group's performance."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
RELATED NEWS
Follow RTT